PE20050461A1 - Composicion farmaceutica en forma de hidrogel para administracion transdermica que comprende un esteroide androgenico - Google Patents

Composicion farmaceutica en forma de hidrogel para administracion transdermica que comprende un esteroide androgenico

Info

Publication number: PE20050461A1
Authority: PE; Peru
Prior art keywords: pharmaceutical composition; steroid; hydrogel; transdermal administration; administration including
Prior art date: 2003-04-28

Application number

PE2004000409A

Other languages

English (en)

Spanish (es)

Inventor

Patrick Franke

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-28

Filing date

2004-04-26

Publication date

2005-08-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33395772&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20050461(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-04-26 Application filed by Schering Ag filed Critical Schering Ag

2005-08-13 Publication of PE20050461A1 publication Critical patent/PE20050461A1/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Neurology (AREA)
Inorganic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

PE2004000409A 2003-04-28 2004-04-26 Composicion farmaceutica en forma de hidrogel para administracion transdermica que comprende un esteroide androgenico PE20050461A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03008856		2003-04-28

Publications (1)

Publication Number	Publication Date
PE20050461A1 true PE20050461A1 (es)	2005-08-13

Family

ID=33395772

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PE2004000409A PE20050461A1 (es)	2003-04-28	2004-04-26	Composicion farmaceutica en forma de hidrogel para administracion transdermica que comprende un esteroide androgenico

Country Status (32)

Country	Link
EP (2)	EP1875905B1 (ru)
JP (2)	JP4829102B2 (ru)
KR (1)	KR101093999B1 (ru)
CN (1)	CN1780610B (ru)
AR (1)	AR044113A1 (ru)
AT (2)	ATE385786T1 (ru)
AU (1)	AU2004233572B2 (ru)
BR (1)	BRPI0409918A (ru)
CA (1)	CA2523734C (ru)
CL (1)	CL2004000884A1 (ru)
CO (1)	CO5640075A2 (ru)
CR (1)	CR8059A (ru)
CY (1)	CY1108069T1 (ru)
DE (2)	DE502004011164D1 (ru)
DK (1)	DK1617827T3 (ru)
EA (1)	EA008686B1 (ru)
EC (1)	ECSP056186A (ru)
ES (2)	ES2345458T3 (ru)
HR (1)	HRP20080178T3 (ru)
JO (1)	JO2492B1 (ru)
MX (1)	MXPA05011541A (ru)
NO (1)	NO20055601L (ru)
NZ (2)	NZ583760A (ru)
PE (1)	PE20050461A1 (ru)
PL (1)	PL1617827T3 (ru)
PT (1)	PT1617827E (ru)
RS (1)	RS51307B (ru)
SI (1)	SI1617827T1 (ru)
TW (1)	TWI343259B (ru)
UA (1)	UA83036C2 (ru)
WO (1)	WO2004096191A1 (ru)
ZA (1)	ZA200509549B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0506141D0 (en) *	2005-03-24	2005-05-04	Transphase Ltd	A topical compostion and its uses
GB0506139D0 (en) *	2005-03-24	2005-05-04	Transphase Ltd	A transdermal topical composition and its uses
DE102005015128B4 (de) *	2005-03-31	2008-12-11	Bayer Schering Pharma Aktiengesellschaft	Wafer enthaltend Steroidhormone
DE102005035879A1 (de) *	2005-07-30	2007-02-01	Paul Hartmann Ag	Hydrogel
SE536091C2 (sv) *	2011-04-14	2013-04-30	Pep Tonic Medical Ab	Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
US20140113887A1 (en) *	2011-04-25	2014-04-24	Jun-Hyoung Park	Composition for topical application for preventing hair loss and stimulating hair growth
FR2976808B1 (fr) *	2011-06-22	2013-06-28	Urgo Lab	Composition filmogene et son utilisation pour le traitement de l'herpes
US9855211B2 (en) *	2013-02-28	2018-01-02	Novan, Inc.	Topical compositions and methods of using the same
DE102018213754A1 (de) *	2018-08-15	2020-02-20	Henkel Ag & Co. Kgaa	"Tris(hydroxymethyl-)aminomethan oder seine Salze als Wirkstoff zur Reduzierung der Schweißsekretion“

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1182229B (de)	1960-11-16	1964-11-26	Upjohn Co	Verfahren zur Herstellung von 7-Methylsteroiden
US3341557A (en)	1961-06-05	1967-09-12	Upjohn Co	7-methyltestosterones
US3924004A (en)	1971-11-24	1975-12-02	Syntex Corp	Fatty alcohol-propylene carbonate-glycol solvent cream vehicle
US4000273A (en)	1973-11-01	1976-12-28	Richardson-Merrell Inc.	Method for the control of fertility
JPS5540604A (en) *	1978-09-14	1980-03-22	Mitsui Toatsu Chem Inc	Improved local topicum
FR2518879A1 (fr) *	1981-12-30	1983-07-01	Besins Jean	Medicament a base d'oestradiol pour le traitement de la pathologie menopausique
JPS5970612A (ja) *	1982-10-13	1984-04-21	Nippon Redarii Kk	ゲル軟膏基剤
AU625150B2 (en) *	1987-05-27	1992-07-02	Kurt Burghart	Transdermal therapeutically effective pharmaceutical dressing and device for applying it
ATE132751T1 (de) *	1988-10-27	1996-01-15	Schering Ag	Mittel zur transdermalen applikation enthaltend gestoden
KR950701508A (ko) *	1992-06-11	1995-04-28	챨스 디 에버트	경피식 약물수송을 조절하기 위한 글리세린의 용도(the use of glycerin in moderating transdermal drug delivery)
US5460620A (en) *	1992-07-31	1995-10-24	Creative Products Resource, Inc.	Method of applying in-tandem applicator pads for transdermal delivery of a therapeutic agent
AU3723695A (en)	1994-09-14	1996-03-29	Minnesota Mining And Manufacturing Company	Transdermal device for delivery of levonorgestrel
FR2732223B1 (fr)	1995-03-30	1997-06-13	Sanofi Sa	Composition pharmaceutique pour administration transdermique
DE19526864A1 (de)	1995-07-22	1997-01-23	Labtec Gmbh	Hormonpflaster
JPH09194396A (ja)	1996-01-17	1997-07-29	Pola Chem Ind Inc	貼付剤用マトリックス
US5733565A (en)	1996-02-23	1998-03-31	The Population Council, Center For Biomedical Research	Male contraceptive implant
KR970064620A (ko) *	1996-03-05	1997-10-13	임성기	사이클로스포린-함유 외용약제 조성물
US5736128A (en) *	1996-05-14	1998-04-07	Isp Investments Inc.	Cosmetic composition for rejuvenation of skin without skin irritation
EP0954260A1 (en)	1996-05-22	1999-11-10	Diversified Pharmaceuticals, Inc.	Compositions, methods and devices for the transdermal delivery of drugs
IT1283102B1 (it) *	1996-06-06	1998-04-07	Permatec Nv	Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
US5993787A (en)	1996-09-13	1999-11-30	Johnson & Johnson Consumer Products, Inc.	Composition base for topical therapeutic and cosmetic preparations
US20020012694A1 (en)	1997-09-17	2002-01-31	Alfred J. Moo-Young	Transdermal administration of ment
US6767902B2 (en)	1997-09-17	2004-07-27	The Population Council, Inc.	Androgen as a male contraceptive and non-contraceptive androgen replacement
SK282796B6 (sk)	1998-06-19	2002-12-03	Akzo Nobel N.V.	Testosterónový derivát, farmaceutický prostriedok s jeho obsahom, jeho použitie a súprava s jeho obsahom
FR2781666B1 (fr) *	1998-07-30	2000-09-08	Oreal	Composition cosmetique solide et ses utilisations
JP2935113B1 (ja) *	1998-09-24	1999-08-16	小林製薬株式会社	インドメタシン経皮吸収剤
AU2003600A (en)	1999-01-13	2000-08-01	Taisho Pharmaceutical Co., Ltd.	External steroid preparation
JP2000264899A (ja) *	1999-01-13	2000-09-26	Taisho Pharmaceut Co Ltd	ステロイド外用剤
JP2001139451A (ja) *	1999-11-17	2001-05-22	Lion Corp	ジェル状化粧料
IL156208A0 (en)	2000-12-15	2003-12-23	Akzo Nobel Nv	14 (15)-unsaturated 15-and/or 16-substituted androgens with mixed androgen-progestational profile
DE10104327A1 (de) *	2001-01-24	2002-07-25	Schering Ag	11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
DE10107663B4 (de)	2001-02-19	2004-09-09	Lts Lohmann Therapie-Systeme Ag	Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung

2004
- 2004-03-25 JO JO200439A patent/JO2492B1/en active
- 2004-04-19 TW TW093110876A patent/TWI343259B/zh not_active IP Right Cessation
- 2004-04-21 BR BRPI0409918-4A patent/BRPI0409918A/pt not_active IP Right Cessation
- 2004-04-21 EP EP07075742A patent/EP1875905B1/de not_active Expired - Lifetime
- 2004-04-21 NZ NZ583760A patent/NZ583760A/en unknown
- 2004-04-21 EP EP04728563A patent/EP1617827B1/de not_active Expired - Lifetime
- 2004-04-21 CA CA002523734A patent/CA2523734C/en not_active Expired - Fee Related
- 2004-04-21 DE DE502004011164T patent/DE502004011164D1/de not_active Expired - Lifetime
- 2004-04-21 SI SI200430685T patent/SI1617827T1/sl unknown
- 2004-04-21 UA UAA200511102A patent/UA83036C2/ru unknown
- 2004-04-21 MX MXPA05011541A patent/MXPA05011541A/es active IP Right Grant
- 2004-04-21 PL PL04728563T patent/PL1617827T3/pl unknown
- 2004-04-21 DE DE502004006196T patent/DE502004006196D1/de not_active Expired - Lifetime
- 2004-04-21 DK DK04728563T patent/DK1617827T3/da active
- 2004-04-21 AU AU2004233572A patent/AU2004233572B2/en not_active Ceased
- 2004-04-21 KR KR1020057020394A patent/KR101093999B1/ko not_active Expired - Fee Related
- 2004-04-21 RS YUP-2005/0809A patent/RS51307B/sr unknown
- 2004-04-21 NZ NZ543264A patent/NZ543264A/en not_active IP Right Cessation
- 2004-04-21 AT AT04728563T patent/ATE385786T1/de active
- 2004-04-21 ES ES07075742T patent/ES2345458T3/es not_active Expired - Lifetime
- 2004-04-21 PT PT04728563T patent/PT1617827E/pt unknown
- 2004-04-21 EA EA200501583A patent/EA008686B1/ru not_active IP Right Cessation
- 2004-04-21 JP JP2006505217A patent/JP4829102B2/ja not_active Expired - Fee Related
- 2004-04-21 AT AT07075742T patent/ATE467412T1/de active
- 2004-04-21 ES ES04728563T patent/ES2300763T3/es not_active Expired - Lifetime
- 2004-04-21 HR HR20080178T patent/HRP20080178T3/xx unknown
- 2004-04-21 CN CN2004800114045A patent/CN1780610B/zh not_active Expired - Fee Related
- 2004-04-21 WO PCT/EP2004/004224 patent/WO2004096191A1/de not_active Ceased
- 2004-04-26 PE PE2004000409A patent/PE20050461A1/es not_active Application Discontinuation
- 2004-04-27 CL CL200400884A patent/CL2004000884A1/es unknown
- 2004-04-28 AR ARP040101436A patent/AR044113A1/es unknown
2005
- 2005-10-24 CR CR8059A patent/CR8059A/es unknown
- 2005-11-24 ZA ZA200509549A patent/ZA200509549B/en unknown
- 2005-11-25 NO NO20055601A patent/NO20055601L/no not_active Application Discontinuation
- 2005-11-25 CO CO05119657A patent/CO5640075A2/es not_active Application Discontinuation
- 2005-11-25 EC EC2005006186A patent/ECSP056186A/es unknown
2008
- 2008-05-13 CY CY20081100503T patent/CY1108069T1/el unknown
2010
- 2010-07-02 JP JP2010152291A patent/JP2010241824A/ja active Pending

Also Published As

Publication number	Publication date
ATE467412T1 (de)	2010-05-15
JP4829102B2 (ja)	2011-12-07
HK1087633A1 (zh)	2006-10-20
NZ543264A (en)	2010-03-26
RS20050809A (sr)	2007-09-21
RS51307B (sr)	2010-12-31
ATE385786T1 (de)	2008-03-15
UA83036C2 (ru)	2008-06-10
CN1780610B (zh)	2010-06-09
EA008686B1 (ru)	2007-06-29
BRPI0409918A (pt)	2006-04-25
EA200501583A1 (ru)	2006-06-30
NO20055601D0 (no)	2005-11-25
CR8059A (es)	2006-05-29
ES2345458T3 (es)	2010-09-23
ZA200509549B (en)	2007-02-28
WO2004096191A1 (de)	2004-11-11
PL1617827T3 (pl)	2008-07-31
CL2004000884A1 (es)	2005-03-11
EP1875905B1 (de)	2010-05-12
JO2492B1 (en)	2009-10-05
HRP20080178T3 (hr)	2008-05-31
ES2300763T3 (es)	2008-06-16
EP1617827B1 (de)	2008-02-13
TWI343259B (en)	2011-06-11
AR044113A1 (es)	2005-08-24
NO20055601L (no)	2006-01-26
CA2523734A1 (en)	2004-11-11
TW200524644A (en)	2005-08-01
EP1617827A1 (de)	2006-01-25
MXPA05011541A (es)	2006-05-31
NZ583760A (en)	2011-10-28
SI1617827T1 (sl)	2008-06-30
CN1780610A (zh)	2006-05-31
PT1617827E (pt)	2008-04-30
CY1108069T1 (el)	2014-02-12
KR20060007403A (ko)	2006-01-24
ECSP056186A (es)	2006-04-19
DK1617827T3 (da)	2008-06-02
JP2006524653A (ja)	2006-11-02
AU2004233572B2 (en)	2010-07-15
DE502004011164D1 (de)	2010-06-24
EP1875905A3 (de)	2008-06-25
AU2004233572A1 (en)	2004-11-11
CA2523734C (en)	2009-12-22
DE502004006196D1 (de)	2008-03-27
KR101093999B1 (ko)	2011-12-15
EP1875905A2 (de)	2008-01-09
JP2010241824A (ja)	2010-10-28
CO5640075A2 (es)	2006-05-31

Publication	Publication Date	Title
EA200971081A1 (ru)	2010-10-29	Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
PE20050461A1 (es)	2005-08-13	Composicion farmaceutica en forma de hidrogel para administracion transdermica que comprende un esteroide androgenico
AR058193A1 (es)	2008-01-23	Composiciones farmaceuticas
CO6190603A2 (es)	2010-08-19	Acido 7-(2-metilpiridin-3-il carbomoil)-4a-benzil-2-(trifluorometil)-1,2,3,4,4a, 9, 10, 10a-octahidro fenantren-2-il-2-fosfonico como moduladores del receptor glucocorticoide
PE20010902A1 (es)	2001-09-06	Derivados de 6-mercapto-ciclodextrina usados como agentes de reversion para el bloqueo neuromuscular inducido por farmacos
GT200800158A (es)	2009-07-09	Pirazolquinolonas como potentes inhibidores de parp
NZ745595A (en)	2019-12-20	Biologically active cannabidiol analogs
PE20090902A1 (es)	2009-07-25	Combinacion de un antimitotico e inhibidor de aurora quinasa como agentes anticancerigenos
PT2038290E (pt)	2013-12-10	Moduladores de receptor do tipo toll 7
PE20071094A1 (es)	2008-01-07	Derivados 1-ortoflurofenil sustituidos 1,2,5-tiadiazolidindionas como inhibidores de ptpasa
ECSP055582A (es)	2005-04-18	Derivados de benzotiazol que tienen actividad agonista de beta-2-adrenorreceptor
BR112014016633A2 (pt)	2017-06-13	estruturas fibrosas com múltiplas regiões contendo agente ativo
AR074778A1 (es)	2011-02-09	Composicion farmaceutica, con anticuerpo monoclonal humano anti - igf-ir.
PE20091583A1 (es)	2009-11-14	Solucion para infusion de dihidropteridinonas estabilizada para el almacenamiento
BRPI0613401B8 (pt)	2021-05-25	composição oftálmica compreendendo derivados de glicocorticoides que penetram seletivamente nos tecidos do segmento posterior
PA8614301A1 (es)	2005-05-10	Derivados de tropano
ES2010224A6 (es)	1989-11-01	Procediniento para la obtencion de nuevas composciones farmaceuticasa base de diclofenac.
PE20080117A1 (es)	2008-02-22	Formulaciones farmaceuticas de una forma cristalina anhidra de 2-(3-fluor-4-hidroxifenil)-7-vinil-1,3-benzoxazol-5-ol
MX2025003905A (es)	2025-05-02	Tiosulfato de sodio anhidro y formulaciones de este
PE20051054A1 (es)	2005-12-16	Compuestos heterociclicos utiles como secretagogos de la hormona de crecimiento
PE20010299A1 (es)	2001-03-07	DERIVADOS DE DECAHIDROISOQUINOLINA COMO ANTAGONISTAS SELECTIVOS DEL RECEPTOR iGLUR5
MX2022001161A (es)	2022-02-22	Derivados de 3,6-diamino-piridazin-3-ilo, composiciones farmaceuticas que los contienen y sus usos como agentes proapoptoticos.
AR078736A1 (es)	2011-11-30	Una solucion de droga de taxanos que comprende un regulador de ph y su metodo de preparacion
ECSP089014A (es)	2009-01-30	18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas), así como preparaciones farmacéuticas que los contienen
PE20020909A1 (es)	2002-12-09	Una combinacion que comprende combretastatina y agentes anticancerigenos

Legal Events

Date	Code	Title	Description
2009-04-28	FG	Grant, registration
2012-11-23	FD	Application declared void or lapsed